tradingkey.logo

Prestige Consumer Healthcare Inc

PBH
66.330USD
+0.780+1.19%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
3.19BValor de mercado
17.43P/L TTM

Prestige Consumer Healthcare Inc

66.330
+0.780+1.19%

Mais detalhes de Prestige Consumer Healthcare Inc Empresa

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.

Informações de Prestige Consumer Healthcare Inc

Código da empresaPBH
Nome da EmpresaPrestige Consumer Healthcare Inc
Data de listagemFeb 10, 2005
CEOLombardi (Ronald M)
Número de funcionários600
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 10
Endereço660 White Plains Rd.
CidadeTARRYTOWN
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal10591
Telefone19145246800
Sitehttps://www.prestigebrands.com/
Código da empresaPBH
Data de listagemFeb 10, 2005
CEOLombardi (Ronald M)

Executivos da empresa Prestige Consumer Healthcare Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-41249.00%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-30855.00%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-3000.00%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+3291.00%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-281.00%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+2094.00%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-6794.00%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+2094.00%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+2094.00%
Mr. John F. Kelly
Mr. John F. Kelly
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-41249.00%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-30855.00%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-3000.00%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+3291.00%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-281.00%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+2094.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: sáb, 10 de jan
Atualizado em: sáb, 10 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.42%
The Vanguard Group, Inc.
11.36%
Ariel Investments, LLC
7.60%
Dimensional Fund Advisors, L.P.
5.48%
Kayne Anderson Rudnick Investment Management, LLC
4.68%
Outro
56.46%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.42%
The Vanguard Group, Inc.
11.36%
Ariel Investments, LLC
7.60%
Dimensional Fund Advisors, L.P.
5.48%
Kayne Anderson Rudnick Investment Management, LLC
4.68%
Outro
56.46%
Tipos de investidores
Investidores
Proporção
Investment Advisor
73.02%
Investment Advisor/Hedge Fund
30.37%
Research Firm
3.34%
Hedge Fund
2.52%
Pension Fund
1.38%
Individual Investor
1.34%
Sovereign Wealth Fund
1.16%
Family Office
0.70%
Bank and Trust
0.53%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
680
53.20M
112.42%
-160.72K
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
6.83M
14.19%
-204.07K
-2.90%
Sep 30, 2025
The Vanguard Group, Inc.
5.48M
11.4%
-140.24K
-2.49%
Sep 30, 2025
Ariel Investments, LLC
3.59M
7.48%
+1.39M
+63.23%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.59M
5.39%
+119.46K
+4.83%
Sep 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
2.21M
4.6%
+464.95K
+26.58%
Sep 30, 2025
State Street Investment Management (US)
1.96M
4.09%
-34.73K
-1.74%
Sep 30, 2025
Nomura Investment Management Business Trust
1.62M
3.37%
-346.31K
-17.60%
Sep 30, 2025
Allspring Global Investments, LLC
1.59M
3.31%
+70.38K
+4.62%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.99%
+24.39K
+1.73%
Sep 30, 2025
Westwood Management Corp. (Texas)
1.14M
2.37%
+259.91K
+29.47%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco Pharmaceuticals ETF
2.44%
State Street SPDR S&P Pharmaceuticals ETF
2.43%
Schwab Ariel Opportunities ETF
2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.05%
Congress SMid Growth ETF
1.94%
Invesco S&P SmallCap Health Care ETF
1.83%
iShares U.S. Pharmaceuticals ETF
1.1%
Brandes US Small-Mid Cap Value ETF
0.84%
Invesco S&P SmallCap Low Volatility ETF
0.71%
JPMorgan Active Small Cap Value ETF
0.68%
Ver Mais
Invesco Pharmaceuticals ETF
Proporção2.44%
State Street SPDR S&P Pharmaceuticals ETF
Proporção2.43%
Schwab Ariel Opportunities ETF
Proporção2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção2.05%
Congress SMid Growth ETF
Proporção1.94%
Invesco S&P SmallCap Health Care ETF
Proporção1.83%
iShares U.S. Pharmaceuticals ETF
Proporção1.1%
Brandes US Small-Mid Cap Value ETF
Proporção0.84%
Invesco S&P SmallCap Low Volatility ETF
Proporção0.71%
JPMorgan Active Small Cap Value ETF
Proporção0.68%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI